ASTRAZEN
ASTRAZENECA PHARMA IND LTHealthcare
LTP
6,707
CHG · %
-4.5 (-0.07%)
VOL · TODAY
1.74K
PREV CLOSE
6,711.5
Today's range6,657 · 6,745
6,707
52-week range6,600 · 9,849.5
6,707
Loading candles…
AstraZeneca Pharma India Ltd operates in the pharmaceutical and biopharmaceutical industries in India. As a subsidiary of the AstraZeneca Group, the company is involved in the manufacture, distribution, and marketing of pharmaceutical products. It focuses on the discovery, development, and commercialization of prescription medicines targeting key therapeutic areas, including Oncology, Cardiovascular, Renal & Metabolism (CVRM), Respiratory & Immunology, and Rare Diseases. The company serves the Indian market by leveraging its parent group's research and development pipeline. No information is available regarding its incorporation year, founders, key management, or stock exchange listings.
ASTRAZEN is not part of any active scan today.
This page is a live market overview for ASTRAZENECA PHARMA IND LT (ASTRAZEN) on the NSE. As a listed security, ASTRAZENECA PHARMA IND LT is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ASTRAZEN before placing trades on tick2trade.
As of the latest feed, ASTRAZEN last traded at ₹6,707 on NSE, down ₹4.5 (0.07%) from the previous close of ₹6,711.5. Today's session range is ₹6,657 – ₹6,745, against a 52-week band of ₹6,600 – ₹9,849.5. Traded volume today stands at 1.74K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for ASTRAZEN in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ASTRAZEN is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ASTRAZENECA PHARMA IND LT before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ASTRAZEN. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ASTRAZEN option chain page linked from this overview.
// similar in healthcare323 total